NDC properties for "Tobi 300 MG per 5 ML Inhalation Solution" (RxCUI 213194)
About this data
The tables show NDC propoerties for Tobi 300 MG per 5 ML Inhalation Solution with the RxCUI 213194
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product
Details for Tobi 300 MG per 5 ML Inhalation Solution (RxCUI 213194)
| MMSL_CODE | BD6531 |
|---|---|
| NDA | NDA050753 |
| RxCUI | 213194 |
| SPL_SET_ID | 6a3c3871-1d3a-44d6-8be3-526b30123ef7 |
| Prescribable Synonym | TOBI 300 MG per 5 ML Inhalation Solution |
| RXNAV_STR | Tobi 60 MG/ML Inhalation Solution |
| RxNorm Name | tobramycin 60 MG/ML Inhalation Solution [Tobi] |
| RxNorm Synonym | Tobi 300 MG per 5 ML Inhalation Solution |
| RxNorm Synonym | Tobi 60 MG/ML Inhalation Solution |
| Related queries | Interactions (for RxCUI 213194) |
NDC Properties
NDC Item 00078049461
| NDC 9 | 0078-0494 |
|---|---|
| NDC 10 | 0078-0494-61 |
| NDC Item | 00078049461 |
| Packaging | 5 mL in 1 AMPULE |
| FDA SPL set id | 644753 |
| Labeler | Novartis Pharmaceuticals Corporation |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA |
| Marketing effective time high | 2022-12-31 |
| Marketing effective time low | 1997-12-22 |
| Marketing status | COMPLETED |
| NDA | NDA050753 |
| Related queries | Properties for NDC 9 0078-0494 |
NDC Item 00078049471
| NDC 9 | 0078-0494 |
|---|---|
| NDC 10 | 0078-0494-71 |
| NDC Item | 00078049471 |
| Packaging | 56 POUCH in 1 CARTON (0078-0494-71) / 4 AMPULE in 1 POUCH (0078-0494-91) / 5 mL in 1 AMPULE (0078-0494-61) |
| FDA SPL set id | 644753 |
| Labeler | Novartis Pharmaceuticals Corporation |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA |
| Marketing effective time high | 2022-12-31 |
| Marketing effective time low | 1997-12-22 |
| Marketing status | COMPLETED |
| NDA | NDA050753 |
| Related queries | Properties for NDC 9 0078-0494 |
NDC Item 49502034573
| NDC 9 | 49502-345 |
|---|---|
| NDC 10 | 49502-345-73 |
| NDC Item | 49502034573 |
| Packaging | 56 POUCH in 1 CARTON (49502-345-73) / 4 AMPULE in 1 POUCH (49502-345-99) / 5 mL in 1 AMPULE |
| FDA SPL set id | 859577 |
| Labeler | Viatris Specialty LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA |
| Marketing effective time low | 2022-06-23 |
| Marketing status | ACTIVE |
| NDA | NDA050753 |
| Related queries | Properties for NDC 9 49502-345 |
NDC Item 49502034599
| NDC 9 | 49502-345 |
|---|---|
| NDC 10 | 49502-345-99 |
| NDC Item | 49502034599 |
| Packaging | 4 in 1 POUCH |
| Packaging | 5 mL in 1 AMPULE |
| FDA SPL set id | 859577 |
| Labeler | Viatris Specialty LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA |
| Marketing effective time low | 2022-06-23 |
| Marketing status | ACTIVE |
| NDA | NDA050753 |
| Related queries | Properties for NDC 9 49502-345 |
NDC Item 00078049461
| NDC 9 | 0078-0494 |
|---|---|
| NDC 10 | 0078-0494-61 |
| NDC Item | 00078049461 |
| Packaging | 5 mL in 1 AMPULE |
| FDA SPL set id | 644753 |
| Labeler | Novartis Pharmaceuticals Corporation |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA |
| Marketing effective time high | 2022-12-31 |
| Marketing effective time low | 1997-12-22 |
| Marketing status | COMPLETED |
| NDA | NDA050753 |
| Related queries | Properties for NDC 9 0078-0494 |
NDC Item 00078049471
| NDC 9 | 0078-0494 |
|---|---|
| NDC 10 | 0078-0494-71 |
| NDC Item | 00078049471 |
| Packaging | 56 POUCH in 1 CARTON (0078-0494-71) / 4 AMPULE in 1 POUCH (0078-0494-91) / 5 mL in 1 AMPULE (0078-0494-61) |
| FDA SPL set id | 644753 |
| Labeler | Novartis Pharmaceuticals Corporation |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA |
| Marketing effective time high | 2022-12-31 |
| Marketing effective time low | 1997-12-22 |
| Marketing status | COMPLETED |
| NDA | NDA050753 |
| Related queries | Properties for NDC 9 0078-0494 |
NDC Item 49502034573
| NDC 9 | 49502-345 |
|---|---|
| NDC 10 | 49502-345-73 |
| NDC Item | 49502034573 |
| Packaging | 56 POUCH in 1 CARTON (49502-345-73) / 4 AMPULE in 1 POUCH (49502-345-99) / 5 mL in 1 AMPULE |
| FDA SPL set id | 859577 |
| Labeler | Viatris Specialty LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA |
| Marketing effective time low | 2022-06-23 |
| Marketing status | ACTIVE |
| NDA | NDA050753 |
| Related queries | Properties for NDC 9 49502-345 |
NDC Item 49502034599
| NDC 9 | 49502-345 |
|---|---|
| NDC 10 | 49502-345-99 |
| NDC Item | 49502034599 |
| Packaging | 4 in 1 POUCH |
| Packaging | 5 mL in 1 AMPULE |
| FDA SPL set id | 859577 |
| Labeler | Viatris Specialty LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA |
| Marketing effective time low | 2022-06-23 |
| Marketing status | ACTIVE |
| NDA | NDA050753 |
| Related queries | Properties for NDC 9 49502-345 |
NDC Item 00078049461
| NDC 9 | 0078-0494 |
|---|---|
| NDC 10 | 0078-0494-61 |
| NDC Item | 00078049461 |
| Packaging | 5 mL in 1 AMPULE |
| FDA SPL set id | 644753 |
| Labeler | Novartis Pharmaceuticals Corporation |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA |
| Marketing effective time high | 2022-12-31 |
| Marketing effective time low | 1997-12-22 |
| Marketing status | COMPLETED |
| NDA | NDA050753 |
| Related queries | Properties for NDC 9 0078-0494 |
NDC Item 00078049471
| NDC 9 | 0078-0494 |
|---|---|
| NDC 10 | 0078-0494-71 |
| NDC Item | 00078049471 |
| Packaging | 56 POUCH in 1 CARTON (0078-0494-71) / 4 AMPULE in 1 POUCH (0078-0494-91) / 5 mL in 1 AMPULE (0078-0494-61) |
| FDA SPL set id | 644753 |
| Labeler | Novartis Pharmaceuticals Corporation |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA |
| Marketing effective time high | 2022-12-31 |
| Marketing effective time low | 1997-12-22 |
| Marketing status | COMPLETED |
| NDA | NDA050753 |
| Related queries | Properties for NDC 9 0078-0494 |
NDC Item 49502034573
| NDC 9 | 49502-345 |
|---|---|
| NDC 10 | 49502-345-73 |
| NDC Item | 49502034573 |
| Packaging | 56 POUCH in 1 CARTON (49502-345-73) / 4 AMPULE in 1 POUCH (49502-345-99) / 5 mL in 1 AMPULE |
| FDA SPL set id | 859577 |
| Labeler | Viatris Specialty LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA |
| Marketing effective time low | 2022-06-23 |
| Marketing status | ACTIVE |
| NDA | NDA050753 |
| Related queries | Properties for NDC 9 49502-345 |
NDC Item 49502034599
| NDC 9 | 49502-345 |
|---|---|
| NDC 10 | 49502-345-99 |
| NDC Item | 49502034599 |
| Packaging | 4 in 1 POUCH |
| Packaging | 5 mL in 1 AMPULE |
| FDA SPL set id | 859577 |
| Labeler | Viatris Specialty LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA |
| Marketing effective time low | 2022-06-23 |
| Marketing status | ACTIVE |
| NDA | NDA050753 |
| Related queries | Properties for NDC 9 49502-345 |
NDC Item 00078049461
| NDC 9 | 0078-0494 |
|---|---|
| NDC 10 | 0078-0494-61 |
| NDC Item | 00078049461 |
| Packaging | 5 mL in 1 AMPULE |
| FDA SPL set id | 644753 |
| Labeler | Novartis Pharmaceuticals Corporation |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA |
| Marketing effective time high | 2022-12-31 |
| Marketing effective time low | 1997-12-22 |
| Marketing status | COMPLETED |
| NDA | NDA050753 |
| Related queries | Properties for NDC 9 0078-0494 |
NDC Item 00078049471
| NDC 9 | 0078-0494 |
|---|---|
| NDC 10 | 0078-0494-71 |
| NDC Item | 00078049471 |
| Packaging | 56 POUCH in 1 CARTON (0078-0494-71) / 4 AMPULE in 1 POUCH (0078-0494-91) / 5 mL in 1 AMPULE (0078-0494-61) |
| FDA SPL set id | 644753 |
| Labeler | Novartis Pharmaceuticals Corporation |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA |
| Marketing effective time high | 2022-12-31 |
| Marketing effective time low | 1997-12-22 |
| Marketing status | COMPLETED |
| NDA | NDA050753 |
| Related queries | Properties for NDC 9 0078-0494 |
NDC Item 49502034573
| NDC 9 | 49502-345 |
|---|---|
| NDC 10 | 49502-345-73 |
| NDC Item | 49502034573 |
| Packaging | 56 POUCH in 1 CARTON (49502-345-73) / 4 AMPULE in 1 POUCH (49502-345-99) / 5 mL in 1 AMPULE |
| FDA SPL set id | 859577 |
| Labeler | Viatris Specialty LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA |
| Marketing effective time low | 2022-06-23 |
| Marketing status | ACTIVE |
| NDA | NDA050753 |
| Related queries | Properties for NDC 9 49502-345 |
NDC Item 49502034599
| NDC 9 | 49502-345 |
|---|---|
| NDC 10 | 49502-345-99 |
| NDC Item | 49502034599 |
| Packaging | 4 in 1 POUCH |
| Packaging | 5 mL in 1 AMPULE |
| FDA SPL set id | 859577 |
| Labeler | Viatris Specialty LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA |
| Marketing effective time low | 2022-06-23 |
| Marketing status | ACTIVE |
| NDA | NDA050753 |
| Related queries | Properties for NDC 9 49502-345 |